Literature DB >> 19843924

Right-to-left ventricular diastolic delay in chronic thromboembolic pulmonary hypertension is associated with activation delay and action potential prolongation in right ventricle.

Maxim Hardziyenka1, Maria E Campian, Berto J Bouma, André C Linnenbank, H A C M Rianne de Bruin-Bon, Jaap J Kloek, Allard C van der Wal, Jan Baan, Edouard M de Beaumont, Herre J Reesink, Jacques M T de Bakker, Paul Bresser, Hanno L Tan.   

Abstract

BACKGROUND: Delayed left ventricle (LV)-to-right ventricle (RV) peak shortening results in cardiac output reduction in patients with chronic thromboembolic hypertension (CTEPH) and other types of pulmonary arterial hypertension. Why the synchrony between LV and RV is lost is unknown. We hypothesized that RV electrophysiological remodeling, notably, conduction slowing and action potential prolongation, contribute to this loss in synchrony. METHODS AND
RESULTS: We conducted epicardial mapping during pulmonary endarterectomy in 26 patients with CTEPH and compared these findings with clinical, hemodynamic, and echocardiographic variables. We consecutively placed a multielectrode grid on the epicardium of the RV free wall and LV lateral wall. These regions corresponded to RV and LV areas where echocardiographic Doppler sample volumes were placed to measure RV-to-LV diastolic interventricular delay. RV and LV epicardial action potential duration was assessed by measuring activation-recovery interval. Onset of diastolic relaxation of RV free wall with respect to LV lateral wall (diastolic interventricular delay) was delayed by 38+/-31 ms in patients with CTEPH versus -12+/-13 ms in control subjects (P<0.001), because, in patients with CTEPH, RV completed electric activation later than LV (65+/-20 versus 44+/-7 ms, P<0.001) and epicardial action potential duration, as assessed by activation-recovery interval measurement, was longer in RV free wall than in LV lateral wall (253+/-29 versus 240+/-22 ms, P<0.001).
CONCLUSIONS: Additive effects of electrophysiological changes in RV, notably, conduction slowing and action potential prolongation, assessed by epicardial activation-recovery interval, contribute to diastolic interventricular delay in patients with CTEPH.

Entities:  

Mesh:

Year:  2009        PMID: 19843924     DOI: 10.1161/CIRCEP.109.856021

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  6 in total

Review 1.  Is cardiac resynchronization therapy for right ventricular failure in pulmonary arterial hypertension of benefit?

Authors:  Jason T Rasmussen; Thenappan Thenappan; David G Benditt; E Kenneth Weir; Marc R Pritzker
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

2.  Diastolic Dysfunction Increases the Risk of Primary Graft Dysfunction after Lung Transplant.

Authors:  Mary K Porteous; Bonnie Ky; James N Kirkpatrick; Russell Shinohara; Joshua M Diamond; Rupal J Shah; James C Lee; Jason D Christie; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

3.  Impact of right ventricular dyssynchrony on left ventricular performance in patients with pulmonary hypertension.

Authors:  Marlieke L A Haeck; Ulas Höke; Nina Ajmone Marsan; Eduard R Holman; Ron Wolterbeek; Jeroen J Bax; Martin J Schalij; Hubert W Vliegen; Victoria Delgado
Journal:  Int J Cardiovasc Imaging       Date:  2014-02-04       Impact factor: 2.357

4.  Adaptation to acute pulmonary hypertension in pigs.

Authors:  Mare Mechelinck; Marc Hein; Sven Bellen; Rolf Rossaint; Anna B Roehl
Journal:  Physiol Rep       Date:  2018-03

5.  Preliminary Study of Right Ventricular Dyssynchrony Under High-Altitude Exposure: Determinants and Impacts.

Authors:  Yuanqi Yang; Chuan Liu; Jingdu Tian; Xiaohan Ding; Shiyong Yu; Shizhu Bian; Jie Yang; Zhexue Qin; Jihang Zhang; Jingbin Ke; Fangzhengyuan Yuan; Chen Zhang; Rongsheng Rao; Lan Huang
Journal:  Front Physiol       Date:  2020-07-02       Impact factor: 4.566

6.  Repolarization Dispersion Is Associated With Diastolic Electromechanical Discoordination in Children With Pulmonary Arterial Hypertension.

Authors:  Michal Schäfer; Benjamin S Frank; D Dunbar Ivy; Max B Mitchell; Kathryn K Collins; Pei-Ni Jone; Johannes C von Alvensleben
Journal:  J Am Heart Assoc       Date:  2022-03-01       Impact factor: 6.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.